Boston Scientific Corporation vs iShares 0 3 Month Treasury Bond ETF — how do they compare? Boston Scientific Corporation trades at $51.07 (market cap $74.19B), while iShares 0 3 Month Treasury Bond ETF trades at $100.51. The key difference: iShares 0 3 Month Treasury Bond ETF is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | SGOV | |
|---|---|---|
Market Cap | $74.19B | — |
Sector | Health | Fixed Income |
52-Week High | $108.14 | $100.74 |
52-Week Low | $42.63 | $100.28 |
Enterprise Value | $86.27B | — |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →